Another study by Bhat and colleagues found that use of an anti-inflammatory modulator that promoted Akt activity in an experimental traumatic brain injury model resulted in decreased pro-inflammatory microglial activation and favorable outcomes in rodents 30. The gene discussed is AKT1; the disease is brain injury.